We're Keeping An Eye On Verici Dx's (LON:VRCI) Cash Burn Rate
Jul 20
U.K. (FTSE) Biotech Industry Analysis
UpdatedJul 20, 2024
DataAggregated Company Financials
Companies23
- 7D-7.6%
- 3M1.5%
- 1Y-28.6%
- YTD-18.2%
Over the last 7 days, the Biotech industry has dropped 7.6%, driven by Genus declining 11%. Meanwhile, Scancell Holdings actually outperformed within the industry, gaining 14% in the last week. Overall the industry is down 29% in 12 months. Earnings are forecast to grow by 26% annually.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 20 Jul 2024 | UK£2.6b | UK£837.9m | -UK£257,011,839.28 | 28.8x | -10x | 3.1x |
| Mon, 17 Jun 2024 | UK£2.6b | UK£835.7m | -UK£273,377,481.57 | 29.4x | -9.6x | 3.1x |
| Wed, 15 May 2024 | UK£3.0b | UK£835.8m | -UK£289,527,504.00 | 31.4x | -10.3x | 3.6x |
| Fri, 12 Apr 2024 | UK£3.1b | UK£902.6m | -UK£201,201,901.13 | 29.1x | -15.4x | 3.4x |
| Sun, 10 Mar 2024 | UK£3.1b | UK£897.4m | -UK£203,115,454.35 | 34.5x | -15.4x | 3.5x |
| Tue, 06 Feb 2024 | UK£3.4b | UK£913.6m | -UK£198,350,507.55 | 31.6x | -17.3x | 3.7x |
| Thu, 04 Jan 2024 | UK£6.4b | UK£1.3b | -UK£245,548,389.00 | 37.5x | -25.9x | 5x |
| Sat, 02 Dec 2023 | UK£6.1b | UK£1.3b | -UK£245,388,294.00 | 35.5x | -24.8x | 4.8x |
| Mon, 30 Oct 2023 | UK£6.4b | UK£1.3b | -UK£253,173,371.00 | 36.9x | -25.1x | 5x |
| Wed, 27 Sep 2023 | UK£6.5b | UK£1.3b | -UK£223,681,158.00 | 23.6x | -29.2x | 5.1x |
| Fri, 25 Aug 2023 | UK£6.6b | UK£1.3b | -UK£208,325,400.00 | 23.6x | -31.8x | 5.3x |
| Sun, 23 Jul 2023 | UK£6.9b | UK£1.3b | -UK£208,433,075.00 | 23.9x | -33.3x | 5.5x |
| Tue, 20 Jun 2023 | UK£7.0b | UK£1.3b | -UK£205,021,515.00 | 23.3x | -34x | 5.5x |
| Thu, 18 May 2023 | UK£6.9b | UK£1.3b | -UK£206,709,835.00 | 22.9x | -33.3x | 5.5x |
| Sat, 15 Apr 2023 | UK£7.2b | UK£1.2b | -UK£154,541,883.00 | 24.2x | -46.9x | 5.8x |
| Mon, 13 Mar 2023 | UK£7.4b | UK£1.2b | -UK£156,769,518.00 | 25.7x | -47x | 5.9x |
| Wed, 08 Feb 2023 | UK£7.5b | UK£1.2b | -UK£147,926,130.00 | 27.2x | -50.8x | 6.4x |
| Fri, 06 Jan 2023 | UK£7.6b | UK£1.2b | -UK£141,883,099.00 | 27.2x | -53.7x | 6.6x |
| Sun, 04 Dec 2022 | UK£7.9b | UK£1.2b | -UK£136,403,672.00 | 24.9x | -57.8x | 6.8x |
| Tue, 01 Nov 2022 | UK£7.2b | UK£1.2b | -UK£142,505,105.00 | 22.7x | -50.8x | 6.2x |
| Thu, 29 Sep 2022 | UK£7.2b | UK£1.2b | -UK£185,906,125.00 | 33.7x | -39x | 6.2x |
| Sat, 27 Aug 2022 | UK£7.3b | UK£1.1b | -UK£145,369,962.00 | 35.8x | -50.3x | 6.6x |
| Mon, 25 Jul 2022 | UK£7.1b | UK£1.1b | -UK£201,735,693.00 | 36.6x | -35.3x | 6.4x |
| Wed, 22 Jun 2022 | UK£6.7b | UK£1.1b | -UK£159,362,449.00 | 35.7x | -42.3x | 6.1x |
| Fri, 20 May 2022 | UK£6.9b | UK£1.1b | -UK£144,950,209.00 | 36.8x | -47.7x | 6.2x |
| Sun, 17 Apr 2022 | UK£7.5b | UK£1.1b | -UK£91,639,220.00 | 40.2x | -81.3x | 6.8x |
| Tue, 15 Mar 2022 | UK£7.7b | UK£1.1b | -UK£134,998,466.00 | 33.2x | -57.2x | 7.1x |
| Thu, 10 Feb 2022 | UK£8.7b | UK£1.1b | -UK£119,952,452.00 | 37.6x | -72.7x | 8x |
| Sat, 08 Jan 2022 | UK£10.7b | UK£1.1b | -UK£120,683,466.00 | 52.9x | -88.4x | 9.8x |
| Mon, 06 Dec 2021 | UK£11.1b | UK£1.1b | -UK£121,503,516.00 | 58.7x | -91x | 10.2x |
| Wed, 03 Nov 2021 | UK£11.8b | UK£1.1b | -UK£145,073,085.00 | 71.4x | -81.4x | 10.9x |
| Fri, 01 Oct 2021 | UK£12.1b | UK£1.1b | -UK£127,504,906.00 | 72x | -95.2x | 11x |
| Sun, 29 Aug 2021 | UK£12.5b | UK£1.0b | -UK£172,541,949.91 | 32x | -72.4x | 12.2x |
Price to Earnings Ratio
-70.3x
Current Industry PE
- Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 6.9x is higher than the industry's current PS ratio of 3.1x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 6.4% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | -1.19% | |
| Healthcare | -0.77% | |
| Biotech | -7.58% | |
| Biotech | -7.58% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SCLP Scancell Holdings | UK£0.13 | 14.0% +UK£14.9m | 20.9% | PE-12.7x | |
| VRCI Verici Dx | UK£0.075 | 15.4% +UK£2.4m | -34.8% | PS5.4x | |
| BVXP Bioventix | UK£41.75 | 0.6% +UK£1.3m | 8.4% | PE25.1x | |
| BSFA BSF Enterprise | UK£0.052 | 16.7% +UK£775.0k | -54.8% | PS80.7x | |
| ONC Oncimmune Holdings | UK£0.11 | 7.3% +UK£555.8k | -35.1% | PS6.7x |
